Patents by Inventor Lina Prasmickaite

Lina Prasmickaite has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9737594
    Abstract: The present invention provides a method of stimulating an immune response to an antigenic molecule, by contacting a cell with the antigenic molecule and with a photosensitizing agent, irradiating the cell, and thereby presenting the antigenic molecule, or part thereof, on the surface of said cell and stimulating an immune response.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: August 22, 2017
    Assignee: PCI Biotech AS
    Inventors: Kristian Berg, Torunn E. Tjelle, Anders Hogset, Lina Prasmickaite
  • Publication number: 20130330363
    Abstract: The present invention provides a method of expressing an antigenic molecule or a part thereof on the surface of an antigen-presenting cell, said method comprising introducing a molecule into the cell cytosol by photochemical internalisation, wherein said molecule, or a part thereof, is subsequently presented on the surface of said cell. Methods of vaccination comprising this method, together with compositions comprising said cells and uses involving said cells expressing antigenic molecules are also provided.
    Type: Application
    Filed: July 5, 2012
    Publication date: December 12, 2013
    Applicant: PCI Biotech AS
    Inventors: Kristian Berg, Torunn E. Tjelle, Anders Hogset, Lina Prasmickaite
  • Patent number: 8216587
    Abstract: The present invention provides a method of expressing an antigenic molecule or a part thereof on the surface of an antigen-presenting cell, said method comprising introducing a molecule into the cell cytosol by photochemical internalisation, wherein said molecule, or a part thereof, is subsequently presented on the surface of said cell. Methods of vaccination comprising this method, together with compositions comprising said cells and uses involving said cells expressing antigenic molecules are also provided.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: July 10, 2012
    Assignee: PCI Biotech AS
    Inventors: Kristian Berg, Torunn E. Tjelle, Anders H øgset, Lina Prasmickaite
  • Patent number: 8008077
    Abstract: The present invention provides a method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: August 30, 2011
    Assignee: PCI Biotech AS
    Inventors: Kristian Berg, Lina Prasmickaite, Anders Hogset, Pal Kristian Selbo
  • Patent number: 7521239
    Abstract: A method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitizing agent, the cell is irradiated with light of a wavelength effective to activate the photosensitizing agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: April 21, 2009
    Assignee: PCI Biotech AS
    Inventors: Anders Høgset, Kristian Berg, Gunhild Mari Mælandsmo, Birgit Øvstebø Engesæter, Lina Prasmickaite
  • Publication number: 20070274953
    Abstract: The present invention provides a method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Application
    Filed: May 9, 2007
    Publication date: November 29, 2007
    Applicant: PCI BIOTECH AS
    Inventors: Kristian BERG, Lina PRASMICKAITE, Anders HOGSET, Pal SELBO
  • Patent number: 7223600
    Abstract: The present invention provides a method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosentistising agent, the cell is irradiated with light of a wavelength effective to activate the photosentisitising agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: May 29, 2007
    Assignee: The Norwegian Radium Hospital Research Foundation
    Inventors: Kristian Berg, Lina Prasmickaite, Anders Høgset, Pål Kristian Selbo
  • Publication number: 20050075268
    Abstract: The present invention provides a method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosentistising agent, the cell is irradiated with light of a wavelength effective to activate the photosentisitising agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Application
    Filed: November 29, 2001
    Publication date: April 7, 2005
    Inventors: Kristian Berg, Lina Prasmickaite, Anders Hogset, Pal Selbo
  • Publication number: 20040096425
    Abstract: The present invention provides a method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the same time or after the irradiation, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination.
    Type: Application
    Filed: November 28, 2003
    Publication date: May 20, 2004
    Inventors: Anders Hogset, Kristian Berg, Gunhild Mari Mlandsmo, Birgit Ovsteb?oslash; Engester, Lina Prasmickaite